New York State Teachers Retirement System (NYSTRS)’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
AVM
SIAU
GP
New York State Teachers Retirement System (NYSTRS)'s VIR Position: Q2 2026 in Review
New York State Teachers Retirement System (NYSTRS) increased its Vir Biotechnology (VIR) stake by 2.9% in Q2 2026, buying an estimated $33.9K and bringing the position to 126,458 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1235.
New York State Teachers Retirement System (NYSTRS) first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.19M in Q2 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.
- New York State Teachers Retirement System (NYSTRS) held 126,458 shares of Vir Biotechnology worth $1.29M as of Q2 2026.
- New York State Teachers Retirement System (NYSTRS) bought 3,558 Vir Biotechnology shares in Q2 2026, an estimated $33.9K.
- Vir Biotechnology made up ﹤0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #1235 holding.
- New York State Teachers Retirement System (NYSTRS) first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
- New York State Teachers Retirement System (NYSTRS)'s Vir Biotechnology position peaked at $2.19M in Q2 2023.
- 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.
Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.